Value proposition

Mission

We harness the power of molecular microbiology to develop diagnostic solutions that will optimize the treatment of life-threatening, drug resistant infections. We seek to dramatically transform patient care to guide antibiotic therapy selection and help improve antibiotic stewardship.

About

Headquartered in Rockville, Maryland, OpGen (NASDAQ:OPGN) is a precision medicine company harnessing the power of molecular diagnostics to help combat infectious disease.

Our innovative approaches to infectious disease diagnostics consist of highly multiplexed syndromic molecular panels to address the global threat of antimicrobial resistance (AMR), improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs).

Together we improve patient care and fight AMR through cutting edge molecular microbiology.

Antibiotic Resistance Testing, Healthcare Associated Infection Surveillance and Epidemiology, Clinical Services Laboratory, DNA Testing, Strain Typing, Bioinformatics, Molecular Diagnostics, and Comparative Genomics